Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Correspondence Activity Detail
Ernexa Therapeutics Inc. (ERNA)
Activity window: Sep. 25, 2025 to Sep. 24, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Mar. 26, 2026 | CORRESP | Neutral/Informational | Moderate | Ernexa Therapeutics Inc. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-3. The company seeks to have the re… | Read Filing EDGAR |
| Mar. 20, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Ernexa Therapeutics Inc. that it will not review the company's registration statement filed on March 16, 2026. The letter emphasizes the company's resp… | Read Filing EDGAR |
| Feb. 3, 2026 | CORRESP | Neutral/Informational | Moderate | Ernexa Therapeutics Inc. has submitted a request for the acceleration of the effective date of their Registration Statement on Form S-1. The request, made through Brookline Capita… | Read Filing EDGAR |
| Feb. 3, 2026 | CORRESP | Neutral/Informational | High | Ernexa Therapeutics Inc. has submitted a request to the SEC for the acceleration of the effectiveness of its Registration Statement on Form S-1. The company seeks to have the regi… | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.